Responses
Clinical trial
A phase III randomized clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer – ENDO-3: ANZGOG trial 1911/2020
Compose a Response to This Article
Other responses
No responses have been published for this article.